Physician profile
Oussama Lawand
NPI 1821283623
$6,818.92
in general payments reported to CMS, 2019-2025
31 companies · $1,632 in 2025
The $1,632 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $339 · 2021: $790 · 2022: $871 · 2023: $1,646 · 2024: $855 · 2025: $1,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,547 · Food and Beverage: $1,516 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,546.83 |
| Food and Beverage | $1,516.16 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $2,059.55 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Na |
| Medical Device Business Services, INC. | $1,407.51 | 2023-2024 | Carto 3 |
| Boston Scientific Corporation | $1,059.61 | 2021-2025 | Watchman Access System, Watchman, Farapulse |
| Biotronik INC. | $485.17 | 2019-2024 | Acticor 7 Vr-T Dx |
| Sanofi-Aventis U.S. LLC | $343.19 | 2019-2022 | |
| Medtronic, INC. | $289.00 | 2021-2025 | Azure Xt Dr Mri Surescan, Selectsecure, Affera Mapping System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.12 | 2019-2022 | |
| Cardiva Medical, INC. | $120.36 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $90.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $87.16 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $79.61 | 2019-2023 | Xarelto |
| Pfizer INC. | $72.22 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $71.42 | 2019-2021 | |
| Amgen INC. | $69.25 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.16 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $45.88 | 2019-2021 | |
| Atricure, INC. | $40.24 | 2021-2024 | |
| Heartflow, INC. | $35.69 | 2022 | |
| Gilead Sciences, INC. | $34.76 | 2019 | |
| Astellas Pharma US INC | $34.03 | 2020-2022 | |
| Medtronic Vascular, INC. | $30.77 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $28.60 | 2019 | |
| Bard Peripheral Vascular, INC. | $28.16 | 2023 | Venclose Maven Catheter |
| Merck Sharp & Dohme LLC | $26.24 | 2021-2022 | |
| Novo Nordisk INC | $18.54 | 2022 | |
| Tactile Systems Technology INC | $17.69 | 2021 | |
| Esperion Therapeutics, INC. | $16.41 | 2021 | |
| Chiesi USA, INC. | $16.23 | 2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $13.95 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $12.80 | 2021 | |
| Philips North America LLC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oussama Lawand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.